ALEXAN

DRUG2 trials

Sponsors

Moleculin Biotech Inc., Instytut Hematologii I Transfuzjologii

Conditions

Acute Myeloid LeukemiaDiffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCLDiffuse large B-cell lymphomas (DLBCLHigh-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiation

Phase 1

Phase 1/2 Study of Liposomal Annamycin in Combination with Cytarabine for the Treatment of Subjects with Acute Myeloid Leukemia (AML).

CompletedCTIS2024-516388-10-00

Moleculin Biotech Inc.Acute Myeloid Leukemia

Start: 2022-09-23End: 2025-08-26Target: 24Updated: 2025-08-29

Phase 2

A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/HGBCL relapse

Not yet recruitingCTIS2024-518275-64-00

Instytut Hematologii I TransfuzjologiiDiffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCL, Diffuse large B-cell lymphomas (DLBCL, High-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiation

Target: 340Updated: 2025-11-24